View online Forward to a friend   |   Facebook   |   Twitter
Pharmaceutical Outsourcing
Featured Articles   |   Featured Partners   |   Videos   |   Service Listings   |   Industry News   |   Events
September 20, 2018
learn more
Newsletter Sponsor
   Metrics Contract Services Continues Strong Focus on FTIM and Phase I Services

For over 20 years, Metrics has been growing and expanding capacities, capabilities, and manufacturing processes for small molecule oral solid dosage forms. Today we want to remind our clients and the industry that we have not lost our focus on where it all began. Metrics continues to invest in equipment and resources to support a healthy foundation of business in the First-time-in-Man/Phase I space. Visit metricscontractservices.com and learn more about how we can support your next project.

more info

» Industry News
 
more news
» Featured Articles
HORIZON LINES: A Quarterly Review of NDAs – January-March 2018
This quarterly review on New Drug Applications contains data for applications approved for the first time during the first quarter of 2018, which includes New Molecular Entities (NMEs) and new ... read more »
Designing Phase-Appropriate Stability Study Programs for Drug Substances and Drug Products
Stability is a critical quality attribute of pharmaceutical products and is a function of many factors, including the active drug substance itself, the excipients used within the formulation, the ... read more »
more articles
 
» Featured Video
learn more
  Watch Video: Pyramid Laboratories Facility Tour
PYRAMID Laboratories, Inc. is a CDMO, focused on parenteral drug products, that offers comprehensive pipeline of services to pharmaceutical and biotech companies. read more »
learn more
  Watch Video: A Discussion with Dr. Thomas Page, VP Engineering and Asset Development at Fujifilm Diosynth Biotechnologies
Watch Video: A Discussion with Dr. Thomas Page, VP Engineering and Asset Development at Fujifilm Diosynth Biotechnologies read more »

more videos
 
» Featured Whitepaper
Considerations for Development of a Lyophilized Biosimilar
The patents for a number of parental biologic formulations are destined to expire in the United States between 2016 and 2027. This provides ... read more »
Process Development for Lyophilized Products
Identifying the failure points for a product is a necessary part of product development, and enables the development scientist to design a ... read more »
more articles
 
| Events
EVENT
  Advancing the Science of Study Endpoints Conference
North Bethesda, MD –  09/20/2018
DIA’s Conference on clinical trial endpoints will bring together key stakeholders to address critical questions and generate potential solutions to ... event details »
EVENT
  Lyophilization USA
Iselin, NJ –  11/15/2018
SMi’s Lyophilization USA conference will look toward the future of lyophilization. Lyophilization is one of the most time-consuming and expensive ... event details »
more events
This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription |  Unsubscribe  | Contact Pharmaceutical Outsourcing


Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA